Royal London Asset Management Portfolio holdings
AUM
$43.8B
1-Year Return
23.68%
This Quarter Return
-5.83%
1 Year Return
+23.68%
3 Year Return
+110.24%
5 Year Return
+184.86%
10 Year Return
–
AUM
$6.21B
AUM Growth
–
Cap. Flow
+$6.21B
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
18.86%
Holding
566
New
566
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Apple
AAPL
|
$256M |
| 2 |
Microsoft
MSFT
|
$136M |
| 3 |
Exxon Mobil
XOM
|
$111M |
| 4 |
Amazon
AMZN
|
$110M |
| 5 |
Walt Disney
DIS
|
$95.8M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Financials | 15.46% |
| 2 | Technology | 14.81% |
| 3 | Healthcare | 14.11% |
| 4 | Consumer Discretionary | 10.94% |
| 5 | Industrials | 9.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
BioMarin Pharmaceuticals
BMRN
$11.1B
| $5.95M | 0.1% |
+56,456
| New | +$5.95M |
|
227
Progressive
PGR
$143B
| $5.94M | 0.1% |
+193,879
| New | +$5.94M |
|
228
Healthpeak Properties
DOC
$12.8B
| $5.93M | 0.1% |
+174,721
| New | +$5.93M |
|
229
Sherwin-Williams
SHW
$92.9B
| $5.92M | 0.1% |
+79,746
| New | +$5.92M |
|
230
Zimmer Biomet
ZBH
$20.9B
| $5.89M | 0.1% |
+64,626
| New | +$5.89M |
|
231
Bread Financial
BFH
$3.09B
| $5.79M | 0.09% |
+28,035
| New | +$5.79M |
|
232
Amphenol
APH
$135B
| $5.72M | 0.09% |
+448,932
| New | +$5.72M |
|
|
SNDK
233
DELISTED
SANDISK CORP
SNDK
| $5.64M | 0.09% |
+103,731
| New | +$5.64M |
|
234
Kellanova
K
$27.8B
| $5.63M | 0.09% |
+90,134
| New | +$5.63M |
|
235
Fifth Third Bancorp
FITB
$30.2B
| $5.61M | 0.09% |
+296,738
| New | +$5.61M |
|
236
International Paper
IP
$25.7B
| $5.58M | 0.09% |
+155,800
| New | +$5.58M |
|
237
Roper Technologies
ROP
$55.8B
| $5.57M | 0.09% |
+35,517
| New | +$5.57M |
|
238
DaVita
DVA
$9.86B
| $5.55M | 0.09% |
+76,737
| New | +$5.55M |
|
239
Omnicom Group
OMC
$15.4B
| $5.55M | 0.09% |
+84,220
| New | +$5.55M |
|
240
Paychex
PAYX
$48.7B
| $5.52M | 0.09% |
+115,900
| New | +$5.52M |
|
241
Devon Energy
DVN
$22.1B
| $5.51M | 0.09% |
+148,550
| New | +$5.51M |
|
242
Alnylam Pharmaceuticals
ALNY
$59.4B
| $5.49M | 0.09% |
+68,258
| New | +$5.49M |
|
243
Incyte
INCY
$16.9B
| $5.48M | 0.09% |
+49,693
| New | +$5.48M |
|
244
Keurig Dr Pepper
KDP
$38.9B
| $5.47M | 0.09% |
+69,231
| New | +$5.47M |
|
245
Edwards Lifesciences
EW
$47.5B
| $5.44M | 0.09% |
+229,494
| New | +$5.44M |
|
246
Northern Trust
NTRS
$24.3B
| $5.43M | 0.09% |
+79,698
| New | +$5.43M |
|
|
VIAB
247
DELISTED
Viacom Inc. Class B
VIAB
| $5.42M | 0.09% |
+125,562
| New | +$5.42M |
|
248
Stanley Black & Decker
SWK
$12.1B
| $5.38M | 0.09% |
+55,497
| New | +$5.38M |
|
249
Las Vegas Sands
LVS
$36.9B
| $5.38M | 0.09% |
+141,616
| New | +$5.38M |
|
250
APA Corp
APA
$8.14B
| $5.34M | 0.09% |
+136,353
| New | +$5.34M |
|